Interstitial granulomatous dermatitis occurring in a patient with SAPHO syndrome one month after starting leflunomide, and subsequently disappearing with ustekinumab

Saved in:
Bibliographic Details
Published inEJD. European journal of dermatology Vol. 26; no. 6; pp. 614 - 615
Main Authors Cornillier, Hélène, Kervarrec, Thibault, Tabareau-Delalande, Flore, Mammou, Saloua, Jonville Bera, Annie-Pierre, Machet, Laurent
Format Journal Article
LanguageEnglish
Published Paris John Libbey Eurotext 01.11.2016
Subjects
Acquired Hyperostosis Syndrome - drug therapy
Adult
Correspondence
Dermatitis - drug therapy
Dermatitis - etiology
Dermatologic Agents - therapeutic use
Dermatology
Drug Eruptions - drug therapy
Drug Eruptions - etiology
Female
Granuloma - chemically induced
Granuloma - drug therapy
Humans
Immunosuppressive Agents - adverse effects
Isoxazoles - adverse effects
Medicine
Medicine & Public Health
Ustekinumab - therapeutic use
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1167-1122
1952-4013
DOI:10.1684/ejd.2016.2854